119 related articles for article (PubMed ID: 9114924)
1. Stability of ondansetron hydrochloride, doxorubicin hydrochloride, and dacarbazine or vincristine sulfate in elastomeric portable infusion devices and polyvinyl chloride bags.
Stewart JT; Warren FW; King DT; Venkateshwaran TG; Ponder GW; Fox JL
Am J Health Syst Pharm; 1997 Apr; 54(8):915-20. PubMed ID: 9114924
[No Abstract] [Full Text] [Related]
2. Stability of doxorubicin hydrochloride and vincristine sulfate in two portable infusion-pump reservoirs.
Nyhammar EK; Johansson SG; Seiving BE
Am J Health Syst Pharm; 1996 May; 53(10):1171-3. PubMed ID: 8734681
[No Abstract] [Full Text] [Related]
3. Stability of ondansetron hydrochloride and five antineoplastic medications.
Stewart JT; Warren FW; King DT; Fox JL
Am J Health Syst Pharm; 1996 Jun; 53(11):1297-300. PubMed ID: 8725205
[No Abstract] [Full Text] [Related]
4. Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastomeric pump supporting transition of the EPOCH regimen to outpatient care.
Svirskis D; Behera S; Naidoo N; Beachman J; Raina T; Zhou Y; Berkahn L; Costello I; Gu Y
J Oncol Pharm Pract; 2019 Jun; 25(4):831-840. PubMed ID: 29540104
[TBL] [Abstract][Full Text] [Related]
5. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Yuan P; Grimes GJ; Shankman SE; Daniels CE; Goldspiel BR; Potti GK
Am J Health Syst Pharm; 2001 Apr; 58(7):594-8. PubMed ID: 11296609
[No Abstract] [Full Text] [Related]
6. Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Dine T; Cazin JC; Gressier B; Luyckx M; Brunet C; Cazin M; Goudaliez F; Mallevais ML; Toraub I
Pharm Weekbl Sci; 1992 Dec; 14(6):365-9. PubMed ID: 1475177
[TBL] [Abstract][Full Text] [Related]
7. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in infusion bags and syringes for 32 days.
Hagan RL; Mallett MS; Fox JL
Am J Health Syst Pharm; 1996 Jun; 53(12):1431-5. PubMed ID: 8781690
[No Abstract] [Full Text] [Related]
8. Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers.
Bougouin C; Thelcide C; Crespin-Maillard F; Maillard C; Kinowski JM; Favier M
Am J Health Syst Pharm; 2005 Oct; 62(19):2001-5. PubMed ID: 16174836
[TBL] [Abstract][Full Text] [Related]
9. Stability of ondansetron and dexamethasone infusion upon refrigeration.
Rolin C; Hecq JD; Vanbeckbergen DF; Jamart J; Galanti LM
Ann Pharmacother; 2011 Jan; 45(1):130-1. PubMed ID: 21156815
[No Abstract] [Full Text] [Related]
10. Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion.
Henry DW; Marshall JL; Nazzaro D; Fox JL; Leff RD
Am J Health Syst Pharm; 1995 Nov; 52(22):2570-3. PubMed ID: 8590244
[No Abstract] [Full Text] [Related]
11. Stability of ondansetron hydrochloride in syrups compounded from tablets.
Williams CL; Sanders PL; Laizure SC; Stevens RC; Fox JL; Hak LJ
Am J Hosp Pharm; 1994 Mar; 51(6):806-9. PubMed ID: 8010321
[No Abstract] [Full Text] [Related]
12. Stability of ondansetron hydrochloride and dexamethasone sodium phosphate in 0.9% sodium chloride injection and in 5% dextrose injection.
Evrard B; Ceccato A; Gaspard O; Delattre L; Delporte JP
Am J Health Syst Pharm; 1997 May; 54(9):1065-8. PubMed ID: 9143656
[No Abstract] [Full Text] [Related]
13. Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC; Chin A; Gill MA
Am J Health Syst Pharm; 1995 Jul; 52(14):1541-3. PubMed ID: 7552896
[TBL] [Abstract][Full Text] [Related]
14. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection.
Wolfe JL; Thoma LA; Du C; Goldspiel BR; Gallelli JF; Grimes GJ; Potti GK
Am J Health Syst Pharm; 1999 May; 56(10):985-9. PubMed ID: 10365723
[No Abstract] [Full Text] [Related]
15. Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH; Neef C; Meuwissen OJ; Rutten JJ; Rosing H; Underberg WJ
Am J Hosp Pharm; 1986 Dec; 43(12):3022-7. PubMed ID: 3812509
[TBL] [Abstract][Full Text] [Related]
16. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
Mayer LD; St-Onge G
Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
[TBL] [Abstract][Full Text] [Related]
17. Ondansetron: design and development of oral pharmaceutical suspensions.
Gallardo Lara V; Gallardo ML; Morales Hernandez ME; Ruiz Martinez MA
Pharmazie; 2009 Feb; 64(2):90-3. PubMed ID: 19320280
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: a stability assessment.
Hecq JD; Lewis AL; Vanbeckbergen D; Athanosopoulos A; Galanti L; Jamart J; Czuczman P; Chung T
J Oncol Pharm Pract; 2013 Mar; 19(1):65-74. PubMed ID: 22801955
[TBL] [Abstract][Full Text] [Related]
19. Stability of midazolam hydrochloride injection 1-mg/mL solutions in polyvinyl chloride and polyolefin bags.
Karlage K; Earhart Z; Green-Boesen K; Myrdal PB
Am J Health Syst Pharm; 2011 Aug; 68(16):1537-40. PubMed ID: 21817086
[TBL] [Abstract][Full Text] [Related]
20. [Platelet concentrate transfusion during polychemotherapy of children with solid tumors].
Koposov PV; KovalevI VI; Strykov VA; Kovalev LV; Loseva MS; Starostina AIu; Prostomolotov OA; Zakharov MV
Vopr Onkol; 2002; 48(3):365-8. PubMed ID: 12455364
[No Abstract] [Full Text] [Related]
[Next] [New Search]
